MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 49 filers reported holding MENLO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,786,000 | – | 74,142 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners L.P. | 1,461,552 | $54,925,000 | 33.85% |
| Vivo Capital, LLC | 4,011,236 | $150,742,000 | 21.35% |
| Novo Holdings A/S | 1,361,313 | $51,158,000 | 6.42% |
| VHCP Management II, LLC | 340,000 | $12,777,000 | 3.08% |
| Perceptive Advisors | 1,598,958 | $60,089,000 | 1.68% |
| Cormorant Asset Management, LP | 336,714 | $12,654,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 426,749 | $16,037,000 | 0.56% |
| Rock Springs Capital Management LP | 330,000 | $12,401,000 | 0.53% |
| NEXTHERA CAPITAL LP | 74,142 | $2,786,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 52,008 | $1,954,000,000 | 0.29% |